Next Generation Smoking Cessation

TTS Pharma careers

Next Generation Smoking Cessation

TTS Pharma currently offer five smoking cessation products for the China market through our 20,000 Sq Ft Beijing GMP
facility. The Company plans a manufacturing hub in Europe that will initially offer an OEM contract sourcing and filling service to satisfy some of the eCig filling demand intended for UK and European markets.

Target Market: The Vape and eCig market has grown at an average 55% CAGR over the past 5 yrs – predominantly in the USA, UK/ Germany and France and continues to grow into new markets as regulations tighten. We will be targeting the UK & European markets.

Customers: As a result of new regulations in the USA and EU, over 1,000 US firms are seeking a GMP compliant bridgehead into Europe.

Jobs

TTS Pharma hasn't added any jobs yet

Get notified when TTS Pharma posts new jobs.

See similar jobs

Founders

View all team members

Karl Knoflach

Founder

Angel Investor & board member of several technology startups in several countries. Karl founded an insurance company and had an exit several years prior.

Sam Sneddon

Founder

Gareth Tempest

Founder

Mark Tucker

Founder

Founder TTS Pharma; Licensed 1st Nicotine patch patent to Novartis; 1st Personalised Medicine spinout from Oxford; invited to supply 30m patients across China

Funding

View all funding

Valuation